Controlled Release Society 2022 Annual Meeting Poster Presentation-News-三迭纪 TRIASTEK

EN
CN

EN

EN
CN

Controlled Release Society 2022 Annual Meeting Poster Presentation

2023-01-06

BACK

PREV NEXT

BACK

Triastek Receives FDA IND Clearance for T25 Octreotide Acetate Tablet

Triastek Receives FDA IND Clearance for T26 Itraconazole Tablet, a 3D Printed Solubility-Enhancing Drug Product

Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance

About

Technology

MED®
Platforms

News

Press Releases
Media Coverage

Contact

Contact Us

BD@triastek.com

苏ICP备2026022692号苏公网安备 32011502011777号

All Rights Reserved

Copyright © 2026 (TRIASTEK)

Contact Us

BD@triastek.com

Follow us on

Global

COPYRIGHT © 2026 TRIASTEK. 苏ICP备2026022692号

DIGITAL By VTHINK